share_log

西点药业(301130.SZ):国投高科及杭州创合拟合计减持不超3%股份

West Pharmaceutical (301130.SZ): Guotou Gaoki and Hangzhou Chuanghe plan to collectively reduce their shareholding by no more than 3%.

Gelonghui Finance ·  Oct 28 23:44

On October 28, GeLongHui announced that China Investment High-Tech and Hangzhou Chuanghe plan to reduce their holdings by a cumulative total of no more than 2,294,700 shares, or 3% of the company's total share capital (excluding repurchases). Among them, within three months after the disclosure date of this announcement, 15 trading days later, the total amount of reduction through centralized competitive trading will not exceed 764,900 shares, or 1% of the company's total share capital (excluding repurchases); within three months after the disclosure date of this announcement, 15 trading days later, the total amount of reduction through block trading will not exceed 1,529,800 shares, or 2% of the company's total share capital (excluding repurchases).

Hengqin Dingdian and Hengqin Runhuiyi plan to reduce their holdings by a cumulative total of no more than 2,294,700 shares, or 3% of the company's total share capital (excluding repurchases). Among them, within three months after the disclosure date of this announcement, 15 trading days later, the total amount of reduction through centralized competitive trading will not exceed 764,900 shares, or 1% of the company's total share capital (excluding repurchases); within three months after the disclosure date of this announcement, 15 trading days later, the total amount of reduction through block trading will not exceed 1,529,800 shares, or 2% of the company's total share capital (excluding repurchases).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment